TH - Theratechnologies Inc.
TSX
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Montreal,
Canada
Type: Equity
TH price evolution
TH
| (in millions $) | 30 Oct 2024 | 31 May 2024 | 29 Feb 2024 | 30 Nov 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $31.17 | $32.24 | $34.1 | |
| Short term investments | $4.86 | $6.21 | $6.76 | |
| Net receivables | $47.29 | $13.56 | $10.5 | $13.55 |
| Inventory | $5.53 | $6.3 | $6.07 | |
| Total current assets | $231.38 | $57.33 | $57.94 | $63.3 |
| Long term investments | ||||
| Property, plant & equipment | $379.17 | $0.92 | $1.82 | $1.98 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $709.78 | $70.21 | $72.09 | $77.77 |
| Current liabilities | ||||
| Accounts payable | $16.92 | $26.28 | $29.93 | $6.99 |
| Deferred revenue | ||||
| Short long term debt | $17.9 | $12.78 | $7.71 | |
| Total current liabilities | $229.29 | $51.98 | $50.32 | $47.29 |
| Long term debt | $0.99 | $41.42 | $46.36 | $51.26 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $292.19 | $93.42 | $96.69 | $98.64 |
| Shareholders' equity | ||||
| Retained earnings | $319.88 | -$412.15 | -$413.14 | -$408.66 |
| Other shareholder equity | -$2.69 | $0.8 | $0.74 | $0.68 |
| Total shareholder equity | -$23.21 | -$24.6 | -$20.87 | |
| (in millions $) | 30 Nov 2023 | 31 Jan 2023 | 30 Nov 2021 | 30 Nov 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $34.1 | $23.86 | $40.35 | $12.74 |
| Short term investments | $6.76 | $10.56 | $22.98 | $8.03 |
| Net receivables | $13.55 | $42.15 | $10.93 | $13.19 |
| Inventory | $6.07 | $19.69 | $29.14 | $25.14 |
| Total current assets | $63.3 | $236.38 | $91.91 | $64.81 |
| Long term investments | ||||
| Property, plant & equipment | $1.98 | $416.32 | $2.85 | $3.48 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $490.68 | |||
| Total investments | ||||
| Total assets | $77.77 | $771.73 | $119.21 | $100.14 |
| Current liabilities | ||||
| Accounts payable | $6.99 | $17.56 | $15.53 | $17.51 |
| Deferred revenue | $6.62 | |||
| Short long term debt | $7.71 | $65.26 | $0.46 | $5.09 |
| Total current liabilities | $47.29 | $190.9 | $45.08 | $41.92 |
| Long term debt | $51.26 | $329.94 | $56.28 | $54.96 |
| Total noncurrent liabilities | $389.82 | |||
| Total debt | ||||
| Total liabilities | $98.64 | $570.88 | $101.45 | $96.92 |
| Shareholders' equity | ||||
| Retained earnings | -$408.66 | $87.68 | -$335.25 | -$300.13 |
| Other shareholder equity | $0.68 | -$2.57 | $4.41 | $3.98 |
| Total shareholder equity | -$20.87 | -$22.57 | $17.76 | $3.22 |
| (in millions $) | 30 Oct 2024 | 31 May 2024 | 29 Feb 2024 | 30 Nov 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $22.02 | $16.25 | $23.45 | |
| Cost of revenue | $4.55 | $5.28 | $5.07 | |
| Gross Profit | $17.47 | $10.96 | $18.39 | |
| Operating activities | ||||
| Research & development | $4.72 | $3.75 | $4.35 | |
| Selling, general & administrative | $9.46 | $9.46 | $7.61 | |
| Total operating expenses | $18.73 | $18.49 | $19.54 | |
| Operating income | $3.29 | -$2.25 | $3.91 | |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.12 | $0.11 | $0.07 | |
| Interest expense | -$2.7 | -$2.65 | -$3.77 | |
| Net income | ||||
| Net income | $0.99 | -$4.48 | -$2.76 | |
| Income (for common shares) | $0.99 | -$4.48 | -$2.76 | |
| (in millions $) | 30 Nov 2023 | 30 Nov 2022 | 30 Nov 2021 | 30 Nov 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $81.76 | $80.06 | $69.82 | $66.05 |
| Cost of revenue | $19.64 | $23.84 | $23.26 | $27.81 |
| Gross Profit | $62.13 | $56.22 | $46.56 | $38.24 |
| Operating activities | ||||
| Research & development | $28.99 | $36.94 | $28.27 | $18.02 |
| Selling, general & administrative | $39.29 | $50.39 | $40.34 | $36.14 |
| Total operating expenses | $90.43 | $113.61 | $95.06 | $84.01 |
| Operating income | -$8.66 | -$33.55 | -$25.24 | -$17.96 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.42 | $0.44 | $0.06 | $0.02 |
| Interest expense | -$11.32 | -$6.5 | ||
| Net income | ||||
| Net income | -$23.96 | -$47.24 | -$31.73 | -$22.67 |
| Income (for common shares) | -$23.96 | -$47.24 | -$31.73 | -$22.67 |
| (in millions $) | 30 Oct 2024 | 31 May 2024 | 29 Feb 2024 | 30 Nov 2023 |
|---|---|---|---|---|
| Net income | $0.99 | -$4.48 | -$2.76 | |
| Operating activities | ||||
| Depreciation | $0.9 | $0.16 | $0.22 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$0.29 | -$1.71 | -$4.11 | |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$23.42 | -$0.14 | $0.13 | $0.14 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $25.16 | |||
| Net borrowings | -$0.12 | -$0.12 | -$0.12 | |
| Total cash flows from financing | -$23.88 | -$0.64 | -$0.28 | $23.09 |
| Effect of exchange rate | -$0.01 | -$0.04 | -$0 | $1.21 |
| Change in cash and equivalents | $73.82 | -$1.07 | -$1.86 | $19.13 |
| (in millions $) | 30 Nov 2023 | 30 Nov 2022 | 30 Nov 2021 | 30 Nov 2020 |
|---|---|---|---|---|
| Net income | -$23.96 | -$47.24 | -$31.73 | -$22.67 |
| Operating activities | ||||
| Depreciation | $0.8 | $0.82 | $0.69 | $0.69 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$5.68 | -$14.69 | -$14.48 | -$13.55 |
| Investing activities | ||||
| Capital expenditures | -$0.32 | -$0.98 | -$0.17 | -$0.03 |
| Investments | ||||
| Total cash flows from investing | $1.11 | $8.68 | -$12.45 | $4.78 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $25.16 | $2.98 | $47.34 | $0.14 |
| Net borrowings | -$7.9 | $10.65 | -$5.63 | -$4.07 |
| Total cash flows from financing | $14.78 | $9.66 | $34.56 | -$7.23 |
| Effect of exchange rate | $1.1 | -$1.03 | $0.04 | $0.08 |
| Change in cash and equivalents | $10.24 | $3.46 | $7.66 | -$15.92 |
News
Fundamentals
| Market cap | $269.82M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 100.30M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -4.73 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.01 |
| Quick ratio | N/A |